Ionis Pharmaceuticals (IONS) Change in Taxes (2019 - 2026)
Ionis Pharmaceuticals (IONS) posted quarterly Change in Taxes of $3000.0 for Q2 2026, up 106.67% year-over-year from $1451.6 in Q2 2025, and down 98.14% quarter-over-quarter from $161000.0 in Q1 2026.
Ionis Pharmaceuticals (IONS) Change in Taxes (2019 - 2026) Analysis & Trends
Ionis Pharmaceuticals' Change in Taxes history runs 8 years deep, the most recent figure standing at $3000.0 for Q2 2026.
- In Q2 2026, Change in Taxes rose 106.67% year-over-year to $3000.0; the TTM figure through Jun 2026 stood at $2.8 million (up 1477.34% YoY), while the FY2025 annual figure was $2.7 million, up 226.55% from the prior year.
- Change in Taxes for Q2 2026 stood at $3000.0, down from $161000.0 in the prior quarter.
- The five-year high for Change in Taxes was $12.0 million in Q2 2024, with the low at -$28.9 million in Q4 2023.
- The 5-year median for Change in Taxes is $56000.0 (2025), against an average of $157833.3.
- Peak annual rise in Change in Taxes reached 316800.0% in 2023, while the deepest fall reached 563.97% in 2023.
- Ionis Pharmaceuticals' Change in Taxes stood at $6.2 million in 2022, then plunged by 563.97% to -$28.9 million in 2023, then soared by 99.98% to -$7000.0 in 2024, then soared by 37414.29% to $2.6 million in 2025, then tumbled by 99.89% to $3000.0 in 2026.
- Business Quant data shows IONS's Change in Taxes at $3000.0 in Q2 2026, $161000.0 in Q1 2026, and $2.6 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Ionis Pharmaceuticals | 9.48 Bn | 7.43 Bn | 265.21 Mn | 3,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3,000.00 |
| Jun 30, 2026 | 3,000.00 |
| Mar 31, 2026 | 161,000.00 |
| Mar 31, 2026 | 161,000.00 |
| Dec 31, 2025 | 2.61 Mn |
| Dec 31, 2025 | 2.61 Mn |
| Sep 30, 2025 | 20,000.00 |
| Sep 30, 2025 | 20,000.00 |
| Jun 30, 2025 | -45,000.00 |
| Jun 30, 2025 | -45,000.00 |
| Mar 31, 2025 | 92,000.00 |
| Mar 31, 2025 | 92,000.00 |
| Dec 31, 2024 | -7,000.00 |
| Dec 31, 2024 | -7,000.00 |
| Sep 30, 2024 | -243,000.00 |
| Sep 30, 2024 | -243,000.00 |
| Jun 30, 2024 | 12.00 Mn |
| Jun 30, 2024 | 12.00 Mn |
| Mar 31, 2024 | -13.87 Mn |
| Mar 31, 2024 | -13.87 Mn |